Sleep Medicine
Feature
What Happens to Surgery Candidates with BHDs and Cancer?
Substance abuse, eating disorders, and sleep disorders were associated with fewer surgeries and greater risk of complications in cancer patients...
From the Journals
Chronic Fatigue Syndrome and Fibromyalgia: A Single Disease Entity?
“The sum of these results does not support the hypothesis that ME/CFS and ME/CFS+FM are distinct entities, as currently defined.”
Latest News
Transcranial Electrical Stimulation Effective for Insomnia
tACS resulted in a statistically significant decrease in insomnia severity compared with the control group.
Latest News
Which Therapies Reduce Daytime Symptoms of Insomnia?
Zolpidem and behavior therapy significantly reduce daytime symptoms such as fatigue, functional impairments, and...
Latest News
Light therapy a beacon of hope for Alzheimer’s?
Light therapy significantly improved sleep and reduced agitation and depression.
Conference Coverage
Sleep disorders linked to increased mortality risk in epilepsy
The mortality risk assessment needs include sleep factors, including sleep disorders and sleep disturbances.
Commentary
More on treating chronic insomnia
In “Treating chronic insomnia: An alternating medication strategy” (Current Psychiatry, October 2023, p. 25-31, doi:10.12788/cp.0397), Dr. Kaplan...
From the Journals
U.S. kids are taking melatonin for sleep, despite evidence gap
These findings should prompt clinicians to discuss with parents the various factors that could be driving sleep disturbances, and potential safety...
From the Journals
Five hours or less of sleep per night tied to subsequent depression
Common genetic markers for short sleep play an important role in the incidence of depression in older adults.
From the Journals
Hitting the snooze button may provide cognitive benefit
“There is no reason to stop snoozing in the morning if you enjoy it, at least not for snooze times around 30 minutes.”
From the Journals
Narcolepsy med shows early promise for adult ADHD
Solriamfetol is a dopamine and norepinephrine reuptake inhibitor that shares some of the properties of current ADHD medications.